Cure rates are climbing, and so is the complexity of getting there. Dr Yara Abdou takes a closer look at optimizing HER2+ early-stage breast cancer therapy.

From per diem shifts to solo practice, physicians share the benefits and costs of working less and living more.

Women with obesity who completed supervised physical activity programs — whether face-to-face or digital — showed marked improvements in self-esteem and body image, with most gains emerging in the ...

Enfortumab vedotin-induced cutaneous toxic effects are linked to improved survival in patients with advanced bladder cancer, a cohort study shows.

Patients with high-risk locally advanced rectal cancer were randomly assigned to receive doublet-LC TNT or conventional neoadjuvant chemoradiotherapy.

Doctors who study ‘medical humanities’ have gained a deeper grasp of how classic works influence and intertwine with modern practice. And they’re better doctors for it.

Patients requiring intensive care for COVID pneumonia have reduced exercise capacity and more frequent restrictive pulmonary function patterns in the early post-COVID period.

Recently approved nonhormonal options can help manage a range of symptoms, and potential new treatments are gaining momentum.

Circulating endotrophin rises with fat gain and falls with fat loss, showing promise as a biomarker of body fat changes and a potential target for reducing obesity-linked health risks.

Etrasimod can be an effective and safe first-line advanced therapy option in patients with ulcerative colitis who escalate after conventional treatment failure.

Exposure to wildfire-sourced fine particulate matter is linked to increased emergency department visits for migraine and other primary headache syndromes, a study shows.

Once-daily oral orforglipron offers an effective weight-loss option for adults aged 65 years or older with overweight or obesity, regardless of type 2 diabetes status.